Clinical Studies of Gemcitabine-Oxaliplatin

NCT00407433 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

156

Enrollment

OTHER

Sponsor class

Conditions

Medulloblastoma
Central Nervous System Tumors
Neuroblastoma
Osteosarcoma

Interventions

DRUG: Gemcitabine (Gemzar®), Oxaliplatin (Eloxatin®)

Sponsor

Gustave Roussy, Cancer Campus, Grand Paris